Novel Epigenetic Target Therapy for Prostate Cancer: A Preclinical Study
نویسندگان
چکیده
منابع مشابه
Novel Epigenetic Target Therapy for Prostate Cancer: A Preclinical Study
Epigenetic events are critical contributors to the pathogenesis of cancer, and targeting epigenetic mechanisms represents a novel strategy in anticancer therapy. Classic demethylating agents, such as 5-Aza-2'-deoxycytidine (Decitabine), hold the potential for reprograming somatic cancer cells demonstrating high therapeutic efficacy in haematological malignancies. On the other hand, epigenetic t...
متن کاملCannabinoid Receptors: A Novel Target for Therapy of Prostate Cancer
Cannabinoids, the active components of Cannabis sativaLinnaeus (marijuana) and their derivatives have receivedrenewed interest in recent years due to their diversepharmacologic activities such as cell growth inhibition,anti-inflammatory effects and tumor regression. Here weshow that expression levels of both cannabinoid receptors,CB1 and CB2, are significantly higher in ...
متن کاملStudy of NGEP expression in androgen sensitive prostate cancer cells: A potential target for immunotherapy
Background: Prostate cancer is one of the leading causes of cancer deaths among men. New gene expressed in prostate (NGEP), is a prostate-specific gene expressed only in normal prostate and prostate cancer tissue. Because of its selective expression in prostate cancer cell surface, NGEP is a potential immunotherapeutic target. To target the NGEP in prostate cancer, it is essential to investig...
متن کاملThe Role of MRSI in Target Volume Definition for Radiation Therapy of Prostate Cancer
Introduction: Recently, magnetic resonance spectroscopic imaging (MRSI), as a functional imaging method, has been used for clinical target volume definition. In this study, we used this method to define the target volume in prostate radiotherapy. Material and Method: In this study, we used images of 20 prostate cancer cases. MRSI and MRI images were fused with CT images. Then, treatment plannin...
متن کاملCancer Therapy: Preclinical Lupeol, a Novel Androgen Receptor Inhibitor: Implications in Prostate Cancer Therapy
Purpose: Conventional therapies to treat prostate cancer (CaP) of androgen-dependent phenotype (ADPC) and castration-resistant phenotype (CRPC) are deficient in outcome which has necessitated a need to identify those agents that could target AR for both disease types. We provide mechanism-based evidence that lupeol (Lup-20(29)-en-3b-ol) is a potent inhibitor of androgen receptor (AR) in vitro
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: PLoS ONE
سال: 2014
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0098101